Through trend analyses, this surveillance highlighted both the emergence and decline of AMR across diverse bacterial pathogens, helping inform which antibiotics may remain appropriate as first-line ...
Background Sociodemographic inequalities impact patients with non-small cell lung cancer (NSCLC). Advances in novel ...
The advent of immune checkpoint inhibitors (ICIs) has marked a paradigm shift in cancer treatment, yet a significant portion of breast cancer patients fail to respond to these therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results